Impact BioMedical, Inc. (IBO)
0.4619
-0.03
(-5.73%)
USD |
NYAM |
Sep 03, 12:49
Impact BioMedical Research and Development Expense (Annual) : 0.34M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.34M |
| December 31, 2024 | 0.278M |
| December 31, 2023 | 1.147M |
| Date | Value |
|---|---|
| December 31, 2022 | 1.226M |
| December 31, 2021 | 1.08M |
| December 31, 2020 | 0.5137M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Enveric Biosciences, Inc. | 2.781M |
| LENZ Therapeutics, Inc. | 18.67M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |
| Veru, Inc. | 15.59M |